Psychemedics Stock Beta
PMD Stock | USD 2.55 0.09 3.41% |
Psychemedics fundamentals help investors to digest information that contributes to Psychemedics' financial success or failures. It also enables traders to predict the movement of Psychemedics Stock. The fundamental analysis module provides a way to measure Psychemedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Psychemedics stock.
Psychemedics | Beta |
Psychemedics Company Beta Analysis
Psychemedics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Psychemedics Beta | 0.7 |
Most of Psychemedics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Psychemedics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Psychemedics Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Psychemedics is extremely important. It helps to project a fair market value of Psychemedics Stock properly, considering its historical fundamentals such as Beta. Since Psychemedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Psychemedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Psychemedics' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, Psychemedics has a Beta of 0.703. This is 18.26% lower than that of the Health Care Providers & Services sector and 51.18% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Psychemedics Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Psychemedics' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Psychemedics could also be used in its relative valuation, which is a method of valuing Psychemedics by comparing valuation metrics of similar companies.Psychemedics is currently under evaluation in beta category among related companies.
Psychemedics Institutional Holders
Institutional Holdings refers to the ownership stake in Psychemedics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Psychemedics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Psychemedics' value.Shares | Santa Monica Partners Lp | 2023-12-31 | 20 K | Northern Trust Corp | 2023-12-31 | 15.3 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 3.5 K | Tower Research Capital Llc | 2023-12-31 | 2.3 K | Your Advocates Ltd., Llp | 2023-12-31 | 1.4 K | Fmr Inc | 2023-12-31 | 625 | Capital Advisors, Ltd. Llc | 2023-09-30 | 60.0 | Wells Fargo & Co | 2023-12-31 | 37.0 | Caldwell Sutter Capital Inc | 2023-12-31 | 30.0 | 22nw, Lp | 2023-12-31 | 274.4 K | Renaissance Technologies Corp | 2023-12-31 | 265.6 K |
As returns on the market increase, Psychemedics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Psychemedics is expected to be smaller as well.
Psychemedics Fundamentals
Return On Equity | -0.48 | ||||
Return On Asset | -0.12 | ||||
Profit Margin | (0.19) % | ||||
Operating Margin | (0.17) % | ||||
Current Valuation | 15.64 M | ||||
Shares Outstanding | 5.81 M | ||||
Shares Owned By Insiders | 22.70 % | ||||
Shares Owned By Institutions | 22.30 % | ||||
Number Of Shares Shorted | 16.88 K | ||||
Price To Earning | 92.08 X | ||||
Price To Book | 2.40 X | ||||
Price To Sales | 0.72 X | ||||
Revenue | 22.1 M | ||||
Gross Profit | 9.29 M | ||||
EBITDA | (251 K) | ||||
Net Income | (4.15 M) | ||||
Cash And Equivalents | 1.79 M | ||||
Cash Per Share | 0.32 X | ||||
Total Debt | 2.3 M | ||||
Debt To Equity | 0.36 % | ||||
Current Ratio | 2.06 X | ||||
Book Value Per Share | 1.15 X | ||||
Cash Flow From Operations | (1.48 M) | ||||
Short Ratio | 1.79 X | ||||
Earnings Per Share | (0.72) X | ||||
Target Price | 32.0 | ||||
Number Of Employees | 116 | ||||
Beta | 0.7 | ||||
Market Capitalization | 15.31 M | ||||
Total Asset | 13.27 M | ||||
Retained Earnings | (16.77 M) | ||||
Working Capital | 2.1 M | ||||
Current Asset | 8.46 M | ||||
Current Liabilities | 3.56 M | ||||
Annual Yield | 0.11 % | ||||
Five Year Return | 5.18 % | ||||
Net Asset | 13.27 M | ||||
Last Dividend Paid | 0.07 |
About Psychemedics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Psychemedics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Psychemedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Psychemedics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Psychemedics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Psychemedics Piotroski F Score and Psychemedics Altman Z Score analysis. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Psychemedics Stock analysis
When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 0.07 | Earnings Share (0.72) | Revenue Per Share 3.85 | Quarterly Revenue Growth (0.12) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.